The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design
Open accessAbstract
There is broad interest in improved methods to generate robust evidence regarding best practice, especially in settings where patient conditions are heterogenous and require multiple concomitant therapies. Here, we present the rationale and design of a large, international trial that combines features of adaptive platform trials with pragmatic point-of-care trials to determine best treatment strategies for patients admitted to an intensive care unit with severe community-acquired pneumonia. The trial uses a novel design, entitled “a randomized embedded multifactorial adaptive platform.” The design has five key features: 1) randomization, allowing robust causal inference; 2) embedding of study procedures into routine care processes, facilitating enrollment, trial efficiency, and generalizability; 3) a multifactorial statistical model comparing multiple interventions across multiple patient subgroups; 4) response-adaptive randomization with preferential assignment to those interventions that appear most favorable; and 5) a platform structured to permit continuous, potentially perpetual enrollment beyond the evaluation of the initial treatments. The trial randomizes patients to multiple interventions within four treatment domains: antibiotics, antiviral therapy for influenza, host immunomodulation with extended macrolide therapy, and alternative corticosteroid regimens, representing 240 treatment regimens. The trial generates estimates of superiority, inferiority, and equivalence between regimens on the primary outcome of 90-day mortality, stratified by presence or absence of concomitant shock and proven or suspected influenza infection. The trial will also compare ventilatory and oxygenation strategies, and has capacity to address additional questions rapidly during pandemic respiratory infections. As of January 2020, REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) was approved and enrolling patients in 52 intensive care units in 13 countries on 3 continents. In February, it transitioned into pandemic mode with several design adaptations for coronavirus disease 2019. Lessons learned from the design and conduct of this trial should aid in dissemination of similar platform initiatives in other disease areas. Clinical trial registered with www.clinicaltrials.gov (NCT02735707).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Self-citationIntravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Self-citationMandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Bellani, G., Laffey, J. G., Pham, T., Fan, E., Brochard, L., Esteban, A., Gattinoni, L., van Haren, F., Larsson, A., McAuley, D. F., et al. (2016) · JAMA · doi:10.1001/jama.2016.0291 · Cited by 5,766
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
Fine, M. J., Auble, T. E., Yealy, D. M., Hanusa, B. H., Weissfeld, L. A., Singer, D. E., Coley, C. M., Marrie, T. J., & Kapoor, W. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701233360402 · Cited by 4,582
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309023291001 · Cited by 4,055
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa040232 · Cited by 2,872
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Effectiveness and Efficiency: Random Reflections on Health Services
(1973) · Public Health · doi:10.1016/s0033-3506(73)80082-4 · Cited by 1,912
Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care
Myburgh, J. A., Finfer, S., Bellomo, R., Billot, L., Cass, A., Gattas, D., Glass, P., Lipman, J., Liu, B., McArthur, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209759 · Cited by 1,687
Self-citationFan, E., Del Sorbo, L., Goligher, E. C., Hodgson, C. L., Munshi, L., Walkey, A. J., Adhikari, N. K. J., Amato, M. B. P., Branson, R., Brower, R. G., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201703-0548st · Cited by 1,630
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
Lim, W. S., Baudouin, S. V., George, R. C., Hill, A. T., Jamieson, C., Le Jeune, I., Macfarlane, J. T., Read, R. C., Roberts, H. J., Levy, M. L., et al. (2009) · Thorax · doi:10.1136/thx.2009.121434 · Cited by 1,420
TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
Wilcox, R. G., Olsson, C. G., Skene, A. M., Von Der Lippe, G., Jensen, G., Hampton, J. R., & For The Asset Study Group (1988) · The Lancet · doi:10.1016/s0140-6736(88)92656-6 · Cited by 1,153
Adjunctive glucocorticoid therapy in patients with septic shock.
Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705835 · Cited by 1,037
Self-citationMaster Protocols to Study Multiple Therapies, Multiple Diseases, or Both
Woodcock, J., & LaVange, L. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1510062 · Cited by 1,020
Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908481 · Cited by 1,001
Guidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 942
Hydrocortisone plus fludrocortisone for adults with septic shock.
Annane, D., Renault, A., Brun-Buisson, C., Megarbane, B., Quenot, J.-P., Siami, S., Cariou, A., Forceville, X., Schwebel, C., Martin, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705716 · Cited by 939
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
Hayden, F. G., Sugaya, N., Hirotsu, N., Lee, N., de Jong, M. D., Hurt, A. C., Ishida, T., Sekino, H., Yamada, K., Portsmouth, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716197 · Cited by 925
Self-citationKilgannon, J. H. (2010) · JAMA · doi:10.1001/jama.2010.707 · Cited by 873
Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., Gravenstein, S., Hayden, F. G., Harper, S. A., Hirshon, J. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy866 · Cited by 795
Methylprednisolone Infusion in Early Severe ARDS
Meduri, G. U., Golden, E., Freire, A. X., Taylor, E., Zaman, M., Carson, S. J., Gibson, M., & Umberger, R. (2007) · Chest · doi:10.1378/chest.06-2100 · Cited by 787
Chu, D. K., Kim, L. H.-Y., Young, P. J., Zamiri, N., Almenawer, S. A., Jaeschke, R., Szczeklik, W., Schünemann, H. J., Neary, J. D., & Alhazzani, W. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30479-3 · Cited by 778
Self-citationI-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
Barker, A., Sigman, C., Kelloff, G., Hylton, N., Berry, D., & Esserman, L. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.68 · Cited by 766
Berry, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1927 · Cited by 726
Girardis, M., Busani, S., Damiani, E., Donati, A., Rinaldi, L., Marudi, A., Morelli, A., Antonelli, M., & Singer, M. (2016) · JAMA · doi:10.1001/jama.2016.11993 · Cited by 723
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
Kanoh, S., & Rubin, B. K. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00078-09 · Cited by 708
Musher, D. M., & Thorner, A. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1312885 · Cited by 626
Bassler, D. (2010) · JAMA · doi:10.1001/jama.2010.310 · Cited by 611
Keh, D., Boehnke, T., Weber-Cartens, S., Schulz, C., Ahlers, O., Bercker, S., Volk, H.-D., Doecke, W.-D., Falke, K. J., & Gerlach, H. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200205-446oc · Cited by 600
Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials
Dobson, J., Whitley, R. J., Pocock, S., & Monto, A. S. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62449-1 · Cited by 594
Statistics and ethics in medical research: III How large a sample?
Altman, D. G. (1980) · BMJ · doi:10.1136/bmj.281.6251.1336 · Cited by 580
Torres, A., Sibila, O., Ferrer, M., Polverino, E., Menendez, R., Mensa, J., Gabarrús, A., Sellarés, J., Restrepo, M. I., Anzueto, A., et al. (2015) · JAMA · doi:10.1001/jama.2015.88 · Cited by 571
Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer
Rugo, H. S., Olopade, O. I., DeMichele, A., Yau, C., van ’t Veer, L. J., Buxton, M. B., Hogarth, M., Hylton, N. M., Paoloni, M., Perlmutter, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513749 · Cited by 554
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
Kapur, J., Elm, J., Chamberlain, J. M., Barsan, W., Cloyd, J., Lowenstein, D., Shinnar, S., Conwit, R., Meinzer, C., Cock, H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1905795 · Cited by 551
Goligher, E. C., Tomlinson, G., Hajage, D., Wijeysundera, D. N., Fan, E., Jüni, P., Brodie, D., Slutsky, A. S., & Combes, A. (2018) · JAMA · doi:10.1001/jama.2018.14276 · Cited by 534
Conservative Oxygen Therapy during Mechanical Ventilation in the ICU
The ICU-ROX Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1903297 · Cited by 511
Guidelines for the management of adult lower respiratory tract infections - Summary
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03602.x · Cited by 468
Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome
Barrot, L., Asfar, P., Mauny, F., Winiszewski, H., Montini, F., Badie, J., Quenot, J.-P., Pili-Floury, S., Bouhemad, B., Louis, G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916431 · Cited by 467
Adaptive Randomization of Neratinib in Early Breast Cancer
Park, J. W., Liu, M. C., Yee, D., Yau, C., van ’t Veer, L. J., Symmans, W. F., Paoloni, M., Perlmutter, J., Hylton, N. M., Hogarth, M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513750 · Cited by 454
Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis
Annane, D., Bellissant, E., Bollaert, P. E., Briegel, J., Keh, D., & Kupfer, Y. (2004) · BMJ · doi:10.1136/bmj.38181.482222.55 · Cited by 443
Adaptive platform trials: definition, design, conduct and reporting considerations
Coalition, T. A. P. T. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0034-3 · Cited by 412
The Platform Trial: An Efficient Strategy for Evaluating Multiple Treatments
Berry, S. M., Connor, J. T., & Lewis, R. J. (2015) · JAMA · doi:10.1001/jama.2015.2316 · Cited by 377
Self-citation(2010) · Essential Facts in Geriatric Medicine · doi:10.1201/9781785231025-47 · Cited by 333
Leroy, O., Santré, C., Beuscart, C., Georges, H., Guery, B. P., Jacquier, J. M., & Beaucaire, G. (1995) · Intensive Care Medicine · doi:10.1007/bf02425150 · Cited by 311
Bodí, M., Rodríguez, A., Solé-Violán, J., Gilavert, M. C., Garnacho, J., Blanquer, J., Jimenez, J., de la Torre, M. V., Sirvent, J. M., Almirall, J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/498119 · Cited by 205
McCabe, C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.259 · Cited by 200
Optimizing the Trade-off Between Learning and Doing in a Pandemic
Angus, D. C. (2020) · JAMA · doi:10.1001/jama.2020.4984 · Cited by 164
Self-citationFusing Randomized Trials With Big Data
Angus, D. C. (2015) · JAMA · doi:10.1001/jama.2015.7762 · Cited by 158
Self-citationArchie Cochrane in his own words
Cochrane, A. L. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90008-1 · Cited by 145
Corticosteroids in Acute Respiratory Failure
Jantz, M. A., & Sahn, S. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.4.9901075 · Cited by 143
Severe Community-Acquired Pneumonia
Sligl, W., & Marrie, T. J. (2013) · Critical Care Clinics · doi:10.1016/j.ccc.2013.03.009 · Cited by 124
Antibiotics for community-acquired pneumonia in adult outpatients
Pakhale, S. S., Mulpuru, S., Verheij, T. J., Kochen, M. M., Rohde, G. G. U., & Bjerre, L. M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002109.pub4 · Cited by 115
Self-citationYoung, P. J., Mackle, D., Bellomo, R., Bailey, M., Beasley, R. W., Deane, A. M., Eastwood, G. M., Finfer, S. R., Freebairn, R., King, V., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05857-x · Cited by 111
Self-citationLamontagne, F., Briel, M., Guyatt, G. H., Cook, D. J., Bhatnagar, N., & Meade, M. O. (2009) · Journal of Critical Care · doi:10.1016/j.jcrc.2009.08.009 · Cited by 108
Self-citationButler, C., van der Velden, A. W., Bongard, E., Saville, B. R., Holmes, J., Coenen, S., Cook, J., Francis, N. A., Lewis, R. J., Godycki-Ćwirko, M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32982-4 · Cited by 107
Self-citationImmunomodulation in Septic Shock
Briegel, J., JOCHUM, M., Gippner‐Steppert, C., & Thiel, M. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12suppl_1s70 · Cited by 103
Fiore, L. D., Brophy, M. T., Ferguson, R. E., DʼAvolio, L., Hermos, J. A., Lew, R., Doros, G. D., Conrad, C. H., O’Neil, J. A., Sabin, T. P., et al. (2011) · Clinical Trials · doi:10.1177/1740774511398368 · Cited by 101
Frei, C. R., Attridge, R. T., Mortensen, E. M., et al. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.02.006 · Cited by 100
Severity assessment in community-acquired pneumonia: a review
Singanayagam, A., Chalmers, J. D., & Hill, A. T. (2009) · QJM · doi:10.1093/qjmed/hcp027 · Cited by 87
Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses.
Briegel, J., Jochum, M., Gippner‐Steppert, C., & Thiel, M. (2001) · PubMed · Cited by 75
Mortensen, E. M., Restrepo, M. I., Anzueto, A., & Pugh, J. A. (2005) · Critical Care · doi:10.1186/cc3934 · Cited by 73
Wiersinga, W. J., Bonten, M. J. M., Boersma, W. G., Jonkers, R. E., Aleva, R. M., Kullberg, B. J., Schouten, J. A., Degener, J. E., Janknegt, R., Verheij, T. J., et al. (2012) · PubMed · Cited by 73
Self-citationOxygen Therapy for the Critically Ill
Angus, D. C. (2020) · New England Journal of Medicine · doi:10.1056/nejme2000800 · Cited by 60
Self-citationSevere community-acquired pneumonia
Álvarez-Lerma, F., & Torres, A. (2004) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000140949.05643.34 · Cited by 31
Corticosteroid Treatment of Severe Community-Acquired Pneumonia
Gorman, S. K., Slavik, R. S., & Marin, J. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h660 · Cited by 25
What is the role of steroids in pneumonia therapy?
Póvoa, P. M. S. R., & Salluh, J. I. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834f44c7 · Cited by 22
WHO downgrades status of oseltamivir
Ebell, M. H. (2017) · BMJ · doi:10.1136/bmj.j3266 · Cited by 21
Bias and Trials Stopped Early for Benefit
Ellenberg, S. S. (2010) · JAMA · doi:10.1001/jama.2010.933 · Cited by 19
Blum, C. A., Nigro, N., Winzeler, B. F., Suter‐Widmer, I., Schüetz, P., Briel, M., Bingisser, R. M., Zimmerli, W., Ullmer, E., Elsaesser, H., et al. (2014) · Trials · doi:10.1186/1745-6215-15-257 · Cited by 18
Oxygen Supplementation Among Patients in the Intensive Care Unit
Girardis, M., & Busani, S. (2017) · JAMA · doi:10.1001/jama.2016.20829 · Cited by 1
Cited by
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne, J. A. C., Murthy, S., Diaz, J. V., Slutsky, A. S., Villar, J., Angus, D. C., Annane, D., Azevedo, L. C. P., Berwanger, O., et al. (2020) · JAMA · doi:10.1001/jama.2020.17023 · Cited by 2,257
Self-citationInterleukin-6 receptor antagonists in critically ill patients with Covid-19.
The REMAP-CAP Investigators (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100433 · Cited by 1,962
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
Maas, A. I. R., Menon, D. K., Manley, G. T., Abrams, M., Åkerlund, C., Andelic, N., Aries, M., Bashford, T., Bell, M. J., Bodien, Y. G., et al. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00309-x · Cited by 1,520
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
The ATTACC, A.-4. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2105911 · Cited by 1,046
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
The REMAP-CAP, A.-4. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2103417 · Cited by 941
Metadata
- Authors
- Angus, D. C., Berry, S., Lewis, R. J., Al-Beidh, F., Arabi, Y., van Bentum-Puijk, W., Bhimani, Z., Bonten, M., Broglio, K., Brunkhorst, F., Cheng, A. C., Chiche, J.-D., De Jong, M., Detry, M., Goossens, H., Gordon, A., Green, C., Higgins, A. M., Hullegie, S. J., Kruger, P., Lamontagne, F., Litton, E., Marshall, J., McGlothlin, A., McGuinness, S., Mouncey, P., Murthy, S., Nichol, A., O’Neill, G. K., Parke, R., Parker, J., Rohde, G., Rowan, K., Turner, A., Young, P., Derde, L., McArthur, C., & Webb, S. A.
- Venue
- Annals of the American Thoracic Society
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-07-01
- Volume
- 17
- Issue
- 7
- Pages
- 879-891
- ISSN
- 2325-6621 (ISSN-L)
- 2329-6933
- OpenAlex
- W3014214532
- Cited by
- 446
- References
- 73
- FWCI
- 39.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.